Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids-Reference-Cited by-同舟云学术

Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids

Published:2022-01-04 Issue:3 Volume:28 Page:364-371
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Wynn Daniel¹,Goldstick Lawrence²,Bauer William³,Zhao Enxu⁴,Tarau Eva⁴,Cohen Jeffrey A.⁵,Robertson Derrick⁶,Miller Aaron⁷

Affiliation:

1. Consultants in Neurology Multiple Sclerosis Center Northbrook Illinois USA

2. University of Cincinnati Waddell Center for Multiple Sclerosis Cincinnati Ohio USA

3. Department of Neurosciences University of Toledo Toledo Ohio USA

4. Mallinckrodt Pharmaceuticals Hampton New Jersey USA

5. Mellen MS Center Cleveland Clinic Cleveland Ohio USA

6. Department of Neurology University of South Florida Tampa Florida USA

7. Icahn School of Medicine at Mount Sinai Hospital New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cns.13789

Reference25 articles.

1. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis;Citterio A;Cochrane Database Syst Rev,2000

2. Acute multiple sclerosis relapse;Berkovich RR;Continuum (Minneap Minn.),2016

3. Impact of multiple sclerosis relapse: The NARCOMS participant perspective

4. Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review

5. European and American Guidelines for Multiple Sclerosis Treatment

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis;CNS Neuroscience & Therapeutics;2023-10-10

2. Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence;Clinical Drug Investigation;2023-10

3. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence;ClinicoEconomics and Outcomes Research;2023-06

4. Acthar Gel Inhibits the Activation of CD4⁺ and CD8⁺ T Cells;Journal of Interferon & Cytokine Research;2023-04-01

5. A Narrative Review of Acthar Gel for the Treatment of Myositis;Rheumatology and Therapy;2023-03-26